 Zee News | Clot-buster drug gets DCGI nod for phase-I human trials Business Standard India's drug controller has cleared for Phase-I human clinical trials an indigenously- developed pioneering clot-buster medicine to treat heart attack patients. Clot-specific Streptokinase (CSSK), a pioneering biotherapeutic clot buster drug from the ... Controller clears clot-buster drug for human trial CSIR lab gets nod for Phase-I clinical trials of clot-buster biotherapeutic drug |
